Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Halloween Pt. 2: PCOS Name Change cover art

Halloween Pt. 2: PCOS Name Change

Halloween Pt. 2: PCOS Name Change

Listen for free

View show details
About this listen

Episode 9: Halloween Pt 2: PCOS Name Change (Plus Hormones 101, the Insulin Loop, and Why You’re Not Overtraining)

Spider-Man and the Green Goblin are back for Part 2, and this time Mia brought her lab coat. PCOS has a new name, and we’re getting into why: the hormones nobody explained in health class, why so many elite athletes seem built for this, the loop keeping lean athletes stuck, and what the evidence says actually helps. Izzy shares her story, Mia drops lab notes to fact-check herself, and we find out live on Google when exactly the balls drop. Fellas, this one’s for you too. Not medical advice; every study we mention is linked below.

Chapters
00:00 — Intro (Part 2 of 2)
03:19 — Hormones 101: Meet the Cast
06:12 — The 10–20x Gap
09:36 — The Day Izzy Cried
12:44 — Love Your Fat (A Lab Note)
14:03 — PCOS Got a Rebrand
17:05 — Built Different
19:27 — The Sticky Review
22:44 — Izzy’s Diagnosis
27:25 — It Runs in the Family
30:58 — Where Hormones Actually Come From
33:49 — The Insulin–Androgen Loop
42:21 — So… What Actually Helps?
46:58 — Not Overtraining, Underfueling
49:41 — Live From Google

Sources

  1. Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407:2329–2339.
  2. Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS. Hum Reprod. 2023;38:1655–1679.
  3. Bozdag G, et al. The prevalence and phenotypic features of PCOS: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855.
  4. Skiba MA, et al. Understanding variation in prevalence estimates of PCOS. Hum Reprod Update. 2018;24(6):694–709.
  5. Hagmar M, et al. Hyperandrogenism may explain reproductive dysfunction in Olympic athletes. Med Sci Sports Exerc. 2009;41(6):1241–1248.
  6. Hirschberg AL. Female hyperandrogenism and elite sport. Endocr Connect. 2020;9(4):R81–R92.
  7. Vink JM, et al. Heritability of PCOS in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–2104.
  8. Risal S, et al. Prenatal androgen exposure and transgenerational susceptibility to PCOS. Nat Med. 2019;25(12):1894–1904.
  9. Stepto NK, et al. Women with PCOS have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777–784.
  10. Cassar S, et al. Insulin resistance in PCOS: a systematic review and meta-analysis of clamp studies. Hum Reprod. 2016;31(11):2619–2631.
  11. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and PCOS revisited. Endocr Rev. 2012;33(6):981–1030.
  12. Melin J, et al. Metformin and combined oral contraceptive pills in the management of PCOS. J Clin Endocrinol Metab. 2023.
  13. Goldberg A, et al. Anti-obesity pharmacological agents for PCOS: a systematic review and meta-analysis. 2024.
  14. Fitz V, et al. Inositol for PCOS: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024.
  15. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab. 2010;95(8):3569–3577.
  16. Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med. 2005;35(4):339–361.
  17. Mountjoy M, et al. 2023 IOC consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073–1097.
  18. Loucks AB, Thuma JR. LH pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab. 2003;88(1):297–311.
  19. Palmert MR, Dunkel L. Delayed puberty. N Engl J Med. 2012;366(5):443–453.
  20. Jonsdottir-Lewis E, et al. Timing of pubertal onset in girls and boys with constitutional delay. J Clin Endocrinol Metab. 2021;106(9):e3693–e3703.
adbl_web_anon_alc_button_suppression_t1
No reviews yet